All Stories

  1. Clinical Effects of Xanthine Oxidase Inhibitors in Hyperuricemic Patients

    Article • Medical Principles and Practice, October 2020, Karger Publishers

    Dr Arrigo FG CICERO

  2. Efficacy and safety of bempedoic acid for the treatment of hypercholesterolemia: A systematic review and meta-analysis

    Article • PLoS Medicine, July 2020, PLOS

    Professor Peter E. Penson, Dr Arrigo FG CICERO, Prof. Maciej Banach, Professor Erkin Mirrakhimov

  3. Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation

    Article • International Journal of Chronic Obstructive Pulmonary Disease, December 2019, Taylor & Francis

    Peter Calverley, Mario Cazzola, Dr Arrigo FG CICERO, edoardo pozzi

  4. Effect of Pycnogenol on Blood Pressure: Findings From a PRISMA Compliant Systematic Review and Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled, Clinical Studies

    Article • Angiology, November 2019, SAGE Publications

    Dr Arrigo FG CICERO, Prof. Maciej Banach

  5. Angiopoietin-like 3 and subclinical peripheral arterial disease: Evidence from the Brisighella Heart Study

    Article • European Journal of Preventive Cardiology, October 2019, SAGE Publications

    Dr Arrigo FG CICERO, Dr Massimiliano Ruscica

  6. Safety and tolerability of injectable lipid-lowering drugs: an update of clinical data

    Article • Expert Opinion on Drug Safety, May 2019, Taylor & Francis

    Federica Fogacci, Dr Arrigo FG CICERO

  7. Current pharmacotherapeutic options for primary dyslipidemia in adults

    Article • Expert Opinion on Pharmacotherapy, May 2019, Taylor & Francis

    Dr Arrigo FG CICERO

  8. Safety and tolerability of available urate-lowering drugs: a critical review

    Article • Expert Opinion on Drug Safety, March 2019, Taylor & Francis

    Dr Arrigo FG CICERO

  9. Sacubitril/valsartan improves both functional and echocardiographic parameters in patients with chronic heart failure with reduced ejection fraction

    Article • Current Medical Research and Opinion, March 2019, Taylor & Francis

    Dr Arrigo FG CICERO

  10. Emerging drugs for the treatment of hypercholesterolemia

    Article • Expert Opinion on Emerging Drugs, January 2019, Taylor & Francis

    Dr Arrigo FG CICERO

  11. Nutraceutical Approach to Peripheral Neuropathies: Evidence from Clinical Trials

    Article • Current Drug Metabolism, May 2018, Bentham Science Publishers

    Dr Arrigo FG CICERO

  12. Polyphenols: Potential Use in the Prevention and Treatment of Cardiovascular Diseases

    Article • Current Pharmaceutical Design, April 2018, Bentham Science Publishers

    Dr Arrigo FG CICERO, Giuseppe Lippi, Prof. Maciej Banach

  13. Polyphenols Effect on Circulating Lipids and Lipoproteins: From Biochemistry to Clinical Evidence

    Article • Current Pharmaceutical Design, April 2018, Bentham Science Publishers

    Dr Arrigo FG CICERO, Dr ALESSANDRO COLLETTI

  14. Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials

    Article • Critical Reviews in Food Science and Nutrition, January 2018, Taylor & Francis

    Giuliano Tocci, Dr Arrigo FG CICERO

  15. Immune modulation by curcumin: The role of interleukin-10

    Article • Critical Reviews in Food Science and Nutrition, August 2017, Taylor & Francis

    Dr Arrigo FG CICERO, Dr Christopher N Blesso

  16. Effects of Carotenoids on Health: Are All the Same? Results from Clinical Trials

    Article • Current Pharmaceutical Design, July 2017, Bentham Science Publishers

    Dr Arrigo FG CICERO

  17. Emerging biologic therapies for hypercholesterolaemia

    Article • Expert Opinion on Biological Therapy, June 2017, Taylor & Francis

    Dr Arrigo FG CICERO

  18. Nutraceuticals and Dietary Supplements to Improve Quality of Life and Outcomes in Heart Failure Patients

    Article • Current Pharmaceutical Design, April 2017, Bentham Science Publishers

    Dr Arrigo FG CICERO

  19. An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia

    Article • Vascular Health and Risk Management, February 2017, Dove Medical Press

    Dr Arrigo FG CICERO

  20. Effect of red yeast rice combined with antioxidants on lipid pattern, hs-CRP level, and endothelial function in moderately hypercholesterolemic subjects

    Article • Therapeutics and Clinical Risk Management, February 2016, Dove Medical Press

    Dr Arrigo FG CICERO, Dr Martino Morbini

  21. Profile of evolocumab and its potential in the treatment of hyperlipidemia

    Article • Drug Design Development and Therapy, June 2015, Dove Medical Press

    Dr Arrigo FG CICERO, Dr ALESSANDRO COLLETTI

  22. Do we need ‘new’ omega-3 polyunsaturated fatty acids formulations?

    Article • Expert Opinion on Pharmacotherapy, December 2014, Informa Healthcare

    Dr Arrigo FG CICERO

  23. Factors associated with 2-year persistence in fully non reimbursed lipid-lowering treatments

    Article • Atherosclerosis, July 2014, Elsevier

    Dr Arrigo FG CICERO

  24. Safety and tolerability of injectable lipid-lowering drugs: a review of available clinical data

    Article • Expert Opinion on Drug Safety, June 2014, Informa Healthcare

    Dr Arrigo FG CICERO

  25. THE TOTAL CARDIOVASCULAR RISK

    Article • May 2014, Taylor & Francis

    Dr Arrigo FG CICERO

  26. Uricaemia and ejection fraction in elderly heart failure outpatients

    Article • European Journal of Clinical Investigation, May 2014, Wiley

    Dr Arrigo FG CICERO

  27. Tinnitus in patients on therapy with proton pump inhibitors (PPI) and in PPI non-users

    Article • Hearing Balance and Communication, May 2014, Taylor & Francis

    Dr Arrigo FG CICERO

  28. Berberine and Monacolin Effects on the Cardiovascular Risk Profile of Women with Oestroprogestin-Induced Hypercholesterolemia

    Article • High Blood Pressure & Cardiovascular Prevention, April 2014, Springer Science + Business Media

    Dr Arrigo FG CICERO

  29. COST EFFECTIVENESS OF ZOFENOPRIL IN THE TREATMENT OF PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION AFTER ACUTE MYOCARDIAL INFARCTION: A POST-HOC ANALYSIS OF THE SMILE-4 STUDY

    Article • Journal of the American College of Cardiology, April 2014, Elsevier

    Prof. Stefano Omboni, Dr Arrigo FG CICERO, Professor Giuseppe Ambrosio

  30. Efficacy and safety profile of evolocumab (AMG145), an injectable inhibitor of the proprotein convertase subtilisin/kexin type 9: the available clinical evidence

    Article • Expert Opinion on Biological Therapy, March 2014, Informa Healthcare

    Dr Arrigo FG CICERO

  31. Cardiovascular drugs and mortality in hypertensive patients with atrial fibrillation: evidence of efficacy for a global approach

    Article • Hypertension Research, March 2014, Springer Science + Business Media

    Dr Arrigo FG CICERO

  32. Diet, dietary supplements and age-related macular degeneration (AMD)

    Article • Nutrafoods, March 2014, Springer Science + Business Media

    Dr Arrigo FG CICERO

  33. Rate of control of LDL cholesterol and incident hypertension requiring antihypertensive treatment in hypercholesterolemic subjects in daily clinical practice

    Article • Annals of Medicine, January 2014, Taylor & Francis

    Dr Arrigo FG CICERO

  34. Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis

    Article • Journal of Hypertension, January 2014, Wolters Kluwer Health

    Dr Arrigo FG CICERO

  35. RETRACTED: Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammation

    Article • European Journal of Pharmaceutical Sciences, January 2014, Elsevier

    Dr Arrigo FG CICERO

  36. Gender Difference in Hepatic Steatosis Index and Lipid Accumulation Product Ability to Predict Incident Metabolic Syndrome in the Historical Cohort of the Brisighella Heart Study

    Article • Metabolic Syndrome and Related Disorders, December 2013, Mary Ann Liebert Inc

    Dr Arrigo FG CICERO

  37. Population Health Needs Assessment and Healthcare Services Use in a 3 Years Follow-Up on Administrative and Clinical Data: Results from the Brisighella Heart Study

    Article • High Blood Pressure & Cardiovascular Prevention, November 2013, Springer Science + Business Media

    Dr Arrigo FG CICERO

  38. Serum uric acid is inversely proportional to estimated stroke volume and cardiac output in a large sample of pharmacologically untreated subjects: data from the Brisighella Heart Study

    Article • Internal and Emergency Medicine, November 2013, Springer Science + Business Media

    Dr Arrigo FG CICERO

  39. Effect of a Lipid-Lowering Nutraceutical on Pulse-Wave-Velocity in Hypercholesterolemic Patients with or without Chronic Kidney Disease

    Article • The Open Hypertension Journal, October 2013, Bentham Science Publishers

    Dr Arrigo FG CICERO

  40. RETRACTED ARTICLE: Different Aspects of Sartan + Calcium Antagonist Association Compared to the Single Therapy on Inflammation and Metabolic Parameters in Hypertensive Patients

    Article • Inflammation, September 2013, Springer Science + Business Media

    Dr Arrigo FG CICERO

  41. Effects of exenatide and metformin in combination on some adipocytokine levels: a comparison with metformin monotherapy

    Article • Canadian Journal of Physiology and Pharmacology, September 2013, Canadian Science Publishing

    Dr Arrigo FG CICERO

  42. Increased Serum Uric Acid as a Risk Factor for Cardiovascular Diseases

    Article • Current Obesity Reports, August 2013, Springer Science + Business Media

    Dr Arrigo FG CICERO

  43. Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects

    Article • Nutrition Research, August 2013, Elsevier

    Dr Arrigo FG CICERO

  44. Evaluation of safety and efficacy of a fixed olmesartan/amlodipine combination therapy compared to single monotherapies

    Article • Expert Opinion on Drug Safety, July 2013, Informa Healthcare

    Dr Arrigo FG CICERO

  45. Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4

    Article • ClinicoEconomics and Outcomes Research, July 2013, Taylor & Francis

    Prof. Stefano Omboni, Dr Arrigo FG CICERO, Professor Giuseppe Ambrosio

  46. How to avoid the depression of the adherence to antihypertensive treatment?

    Article • Journal of Hypertension, July 2013, Wolters Kluwer Health

    Dr Arrigo FG CICERO

  47. Effect of Zofenopril and Ramipril on Cardiovascular Mortality in Patients With Chronic Heart Failure

    Article • The American Journal of Cardiology, July 2013, Elsevier

    Dr Arrigo FG CICERO

  48. RETRACTED: Evaluation of the positive effects on insulin-resistance and β-cell measurements of vildagliptin in addition to metformin in type 2 diabetic patients

    Article • Pharmacological Research, July 2013, Elsevier

    Dr Arrigo FG CICERO

  49. Zofenopril and ramipril and acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction

    Article • Journal of Hypertension, June 2013, Wolters Kluwer Health

    Prof. Stefano Omboni, Dr Arrigo FG CICERO, Professor Giuseppe Ambrosio

  50. Combined Nutraceutical Approach to Postmenopausal Syndrome and Vascular Remodeling Biomarkers

    Article • The Journal of Alternative and Complementary Medicine, June 2013, Mary Ann Liebert Inc

    Dr Arrigo FG CICERO

  51. A Randomized, Double-Blind, Comparative Therapy Evaluating Sitagliptin Versus Glibenclamide in Type 2 Diabetes Patients Already Treated with Pioglitazone and Metformin: A 3-Year Study

    Article • Diabetes Technology & Therapeutics, March 2013, Mary Ann Liebert Inc

    Dr Arrigo FG CICERO

  52. Evidence of Clinically Relevant Efficacy for Dietary Supplements and Nutraceuticals

    Article • Current Hypertension Reports, February 2013, Springer Science + Business Media

    Dr Arrigo FG CICERO

  53. Influence of metabolic syndrome superposition on familial combined hyperlipoproteinemia cardiovascular complication rate

    Article • Archives of Medical Science, January 2013, Termedia Sp. z.o.o.

    Dr Arrigo FG CICERO

  54. State of the art paper Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiology

    Article • Archives of Medical Science, January 2013, Termedia Sp. z.o.o.

    Dr Arrigo FG CICERO

  55. Variations in Inflammatory Biomarkers Following the Addition of Sitagliptin in Patients with Type 2 Diabetes not Controlled with Metformin

    Article • Internal Medicine, January 2013, Japanese Society of Internal Medicine

    Dr Arrigo FG CICERO

  56. RETRACTED: Variation of some inflammatory markers in hypertensive patients after 1 year of olmesartan/amlodipine single-pill combination compared with olmesartan or amlodipine monotherapies

    Article • Journal of the American Society of Hypertension, January 2013, Elsevier

    Dr Arrigo FG CICERO

  57. Hepatic Steatosis Index and Lipid Accumulation Product as middle-term predictors of incident metabolic syndrome in a large population sample: data from the Brisighella Heart Study

    Article • Internal and Emergency Medicine, November 2012, Springer Science + Business Media

    Dr Arrigo FG CICERO

  58. Vildagliptin action on some adipocytokine levels in type 2 diabetic patients: a 12-month, placebo-controlled study

    Article • Expert Opinion on Pharmacotherapy, November 2012, Informa Healthcare

    Dr Arrigo FG CICERO

  59. Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: Evaluation with euglycemic clamp and oral fat load

    Article • Journal of Clinical Lipidology, November 2012, Elsevier

    Dr Arrigo FG CICERO, Dr Aldo Bonaventura

  60. A randomized, double-blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and β-cell function

    Article • Expert Opinion on Pharmacotherapy, October 2012, Informa Healthcare

    Dr Arrigo FG CICERO

  61. Sitagliptin added to previously taken antidiabetic agents on insulin resistance and lipid profile: a 2‐year study evaluation

    Article • Fundamental and Clinical Pharmacology, October 2012, Wiley

    Dr Arrigo FG CICERO, Dr Aldo Bonaventura

  62. Nutraceuticals with lipid-lowering activity: do they have any effect beyond cholesterol reduction?

    Article • Clinical Lipidology, October 2012, Future Medicine

    Dr Arrigo FG CICERO

  63. Effects of a combination of sitagliptin plus metformin vs metformin monotherapy on glycemic control, β-cell function and insulin resistance in type 2 diabetic patients

    Article • Diabetes Research and Clinical Practice, October 2012, Elsevier

    Dr Arrigo FG CICERO, Dr Aldo Bonaventura

  64. Olmesartan/Amlodipine Combination Versus Olmesartan or Amlodipine Monotherapies on Blood Pressure and Insulin Resistance in a Sample of Hypertensive Patients

    Article • Clinical and Experimental Hypertension, September 2012, Taylor & Francis

    Dr Arrigo FG CICERO

  65. Leisure-time physical activity and cardiovascular disease mortality

    Article • Journal of Cardiovascular Medicine, September 2012, Wolters Kluwer Health

    Dr Arrigo FG CICERO

  66. Hypertension: management perspectives

    Article • Expert Opinion on Pharmacotherapy, July 2012, Informa Healthcare

    Dr Arrigo FG CICERO

  67. Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects

    Article • Expert Opinion on Drug Safety, July 2012, Informa Healthcare

    Dr Arrigo FG CICERO

  68. Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials

    Article • Expert Opinion on Biological Therapy, July 2012, Informa Healthcare

    Dr Arrigo FG CICERO

  69. Increasing Diagnosis of Thyroid Papillary Carcinoma Follicular Variant in South-East Anatolian Region: Comparison of Characteristics of Classical Papillary and Follicular Variant Thyroid Cancers

    Article • Endocrine Pathology, June 2012, Springer Science + Business Media

    Dr Arrigo FG CICERO

  70. Which statin is the ideal statin for polymedicated patients?

    Article • Clinical Lipidology, June 2012, Future Medicine

    Dr Arrigo FG CICERO

  71. Long-term efficacy and tolerability of a multicomponent lipid-lowering nutraceutical in overweight and normoweight patients

    Article • Nutrafoods, June 2012, Springer Science + Business Media

    Dr Arrigo FG CICERO

  72. Vildagliptin Added to Metformin on β-Cell Function After a Euglycemic Hyperinsulinemic and Hyperglycemic Clamp in Type 2 Diabetes Patients

    Article • Diabetes Technology & Therapeutics, June 2012, Mary Ann Liebert Inc

    Dr Arrigo FG CICERO, Dr Aldo Bonaventura

  73. Antidiabetic Properties of Berberine: From Cellular Pharmacology to Clinical Effects

    Article • Hospital Practice, April 2012, Taylor & Francis

    Dr Arrigo FG CICERO

  74. The Role of Irbesartan in the Treatment of Patients with Hypertension

    Article • High Blood Pressure & Cardiovascular Prevention, March 2012, Springer Science + Business Media

    Dr Arrigo FG CICERO

  75. Relationship between blood pressure, cholesterolemia and serum apolipoprotein B in a large population sample

    Article • Journal of Hypertension, March 2012, Wolters Kluwer Health

    Dr Arrigo FG CICERO

  76. Activity of isoflavones and berberine on vasomotor symptoms and lipid profile in menopausal women

    Article • Gynecological Endocrinology, February 2012, Taylor & Francis

    Dr Arrigo FG CICERO

  77. 25-Hydroxy vitamin D levels and endothelial vasodilator function in normotensive women

    Article • Archives of Medical Science, January 2012, Termedia Sp. z.o.o.

    Dr Arrigo FG CICERO

  78. State of the art paper Application of polyunsaturated fatty acids in internal medicine: beyond the established cardiovascular effects

    Article • Archives of Medical Science, January 2012, Termedia Sp. z.o.o.

    Dr Arrigo FG CICERO

  79. State of the art paper Impact of physical activity on inflammation: effects on cardiovascular disease risk and other inflammatory conditions

    Article • Archives of Medical Science, January 2012, Termedia Sp. z.o.o.

    Dr Arrigo FG CICERO

  80. Metabolic Syndrome, Adipokines and Hormonal Factors in Pharmacologically Untreated Adult Elderly Subjects from the Brisighella Heart Study Historical Cohort

    Article • Obesity Facts, January 2012, Karger Publishers

    Dr Arrigo FG CICERO, Dr Massimiliano Ruscica

  81. Mini-Special Issue paper Management of diabetic patients with hypoglycemic agents Metformin and its clinical use: new insights for an old drug in clinical practice

    Article • Archives of Medical Science, January 2012, Termedia Sp. z.o.o.

    Dr Arrigo FG CICERO

  82. Eulipidemic Effects of Berberine Administered Alone or in Combination with Other Natural Cholesterol-lowering Agents

    Article • Arzneimittelforschung, December 2011, Thieme Publishing Group

    Dr Arrigo FG CICERO

  83. Kidney disease and inner ear impairment: a simpler and closer pathogenic analogy?

    Article • Internal and Emergency Medicine, October 2011, Springer Science + Business Media

    Dr Arrigo FG CICERO

  84. Blood Pressure and Metabolic Effect of a Combination of Lercanidipine with Different Antihypertensive Drugs in Clinical Practice

    Article • Clinical and Experimental Hypertension, October 2011, Taylor & Francis

    Dr Arrigo FG CICERO

  85. Hypertension and diabetes incidence: confounding factors

    Article • Hypertension Research, July 2011, Springer Science + Business Media

    Dr Arrigo FG CICERO

  86. Lactotripeptides effect on office and 24-h ambulatory blood pressure, blood pressure stress response, pulse wave velocity and cardiac output in patients with high-normal blood pressure or first-degree hypertension: a randomized double-blind clinical trial

    Article • Hypertension Research, July 2011, Springer Science + Business Media

    Dr Arrigo FG CICERO

  87. RETRACTED: Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study

    Article • Journal of Diabetes and its Complications, July 2011, Elsevier

    Dr Arrigo FG CICERO

  88. Tinnitus in elderly patients and prognosis of mild-to-moderate congestive heart failure: a cross-sectional study with a long-term extension of the clinical follow-up

    Article • BMC Medicine, June 2011, Springer Science + Business Media

    Dr Arrigo FG CICERO

  89. Effects of n‐3 PUFA on insulin resistance after an oral fat load

    Article • European Journal of Lipid Science and Technology, June 2011, Wiley

    Dr Arrigo FG CICERO, Dr Aldo Bonaventura

  90. From risk factor assessment to cardiovascular disease risk and mortality modification: the first 40 years of the Brisighella Heart Study

    Article • Clinical Lipidology, June 2011, Future Medicine

    Dr Arrigo FG CICERO

  91. Effects of combination of sibutramine and l-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients

    Article • Metabolism, March 2011, Elsevier

    Dr Arrigo FG CICERO

  92. The relationship between calcium metabolism, insulin-like growth factor-1 and pulse pressure in normotensive, normolipidaemic and non-diabetic patients

    Article • Archives of Medical Science, January 2011, Termedia Sp. z.o.o.

    Dr Arrigo FG CICERO

  93. Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load

    Article • European Journal of Pharmacology, January 2011, Elsevier

    Dr Arrigo FG CICERO

  94. Adipokines and Sexual Hormones Associated with the Components of the Metabolic Syndrome in Pharmacologically Untreated Subjects: Data from the Brisighella Heart Study

    Article • International Journal of Endocrinology, January 2011, Hindawi Publishing Corporation

    Dr Arrigo FG CICERO, Dr Massimiliano Ruscica

  95. Rationale for the Use of a Fixed-Dose Combination in the Management of Hypertension

    Article • Clinical Drug Investigation, December 2010, Springer Science + Business Media

    Dr Arrigo FG CICERO

  96. Hemodynamic Effects of Lactotripeptides from Casein Hydrolysate in Mediterranean Normotensive Subjects and Patients with High-Normal Blood Pressure: A Randomized, Double-Blind, Crossover Clinical Trial

    Article • Journal of Medicinal Food, December 2010, Mary Ann Liebert Inc

    Dr Arrigo FG CICERO

  97. Hemodynamic and neurohumoral profile in patients with different types of hypertension in pregnancy

    Article • Internal and Emergency Medicine, November 2010, Springer Science + Business Media

    Dr Arrigo FG CICERO

  98. Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patients

    Article • Hypertension Research, November 2010, Springer Science + Business Media

    Dr Arrigo FG CICERO

  99. Comparison between orlistat plus l‐carnitine and orlistat alone on inflammation parameters in obese diabetic patients

    Article • Fundamental and Clinical Pharmacology, November 2010, Wiley

    Dr Arrigo FG CICERO

  100. Rationale for the Use of a Fixed-Dose Combination in the Management of Hypertension

    Article • Clinical Drug Investigation, September 2010, Springer Science + Business Media

    Dr Arrigo FG CICERO

  101. Psychosocial factors and metabolic parameters: Is there any association in elderly people? The Massa Lombarda Project

    Article • Aging & Mental Health, September 2010, Taylor & Francis

    Dr Arrigo FG CICERO

  102. Relationship between serum zinc levels, thyroid hormones and thyroid volume following successful iodine supplementation

    Article • HORMONES, July 2010, Hellenic Endocrine Society

    Dr Arrigo FG CICERO

  103. Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered

    Article • International Journal of Nephrology and Renovascular Disease, July 2010, Taylor & Francis

    Dr Arrigo FG CICERO

  104. Comparison of orlistat treatment and placebo in obese type 2 diabetic patients

    Article • Expert Opinion on Pharmacotherapy, June 2010, Informa Healthcare

    Dr Arrigo FG CICERO

  105. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients

    Article • Metabolism, June 2010, Elsevier

    Dr Arrigo FG CICERO

  106. Differential effects of candesartan and olmesartan on adipose tissue activity biomarkers in type II diabetic hypertensive patients

    Article • Hypertension Research, May 2010, Springer Science + Business Media

    Dr Arrigo FG CICERO

  107. Red Yeast Rice and Statin-Intolerant Patients

    Article • The American Journal of Cardiology, May 2010, Elsevier

    Dr Arrigo FG CICERO

  108. Omega 3 Polyunsaturated Fatty Acids Supplementation and Blood Pressure Levels in Hypertriglyceridemic Patients with Untreated Normal-High Blood Pressure and With or Without Metabolic Syndrome: A Retrospective Study

    Article • Clinical and Experimental Hypertension, April 2010, Taylor & Francis

    Dr Arrigo FG CICERO

  109. Modification of vascular and inflammation biomarkers after OGTT in overweight healthy and diabetic subjects

    Article • Microvascular Research, March 2010, Elsevier

    Dr Arrigo FG CICERO

  110. Weight loss and blood pressure normalization: the relevance of early interventions in hypertension

    Article • Hypertension Research, January 2010, Springer Science + Business Media

    Dr Arrigo FG CICERO

  111. Candesartan effect on inflammation in hypertension

    Article • Hypertension Research, January 2010, Springer Science + Business Media

    Dr Arrigo FG CICERO

  112. A Web2.0 Platform in Healthcare Created on the Basis of the Real Perceived Need of the Elderly End User

    Article • January 2010, Springer Science + Business Media

    Giovanni Rinaldi, Dr Arrigo FG CICERO

  113. Preclinical and clinical evidence of nephro- and cardiovascular protective effects of glycosaminoglycans

    Article • Archives of Medical Science, January 2010, Termedia Sp. z.o.o.

    Dr Arrigo FG CICERO

  114. Long-term Effect of a Dietary Education Program on Postmenopausal Cardiovascular Risk and Metabolic Syndrome: The Brisighella Heart Study

    Article • Journal of Women s Health, January 2010, Mary Ann Liebert Inc

    Dr Arrigo FG CICERO

  115. Sibutramine and L-Carnitine Compared to Sibutramine Alone on Insulin Resistance in Diabetic Patients

    Article • Internal Medicine, January 2010, Japanese Society of Internal Medicine

    Dr Arrigo FG CICERO

  116. Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients

    Article • Endocrine Journal, January 2010, Japan Endocrine Society

    Dr Arrigo FG CICERO

  117. Modulation of adipokines and vascular remodelling markers during OGTT with acarbose or pioglitazone treatment

    Article • Biomedicine & Pharmacotherapy, December 2009, Elsevier

    Dr Arrigo FG CICERO

  118. Effect of a sequential training programme on inflammatory, prothrombotic and vascular remodelling biomarkers in hypertensive overweight patients with or without metabolic syndrome

    Article • European Journal of Cardiovascular Prevention & Rehabilitation, December 2009, Oxford University Press (OUP)

    Dr Arrigo FG CICERO

  119. Metabolic and cardiovascular effects of berberine: from preclinical evidences to clinical trial results

    Article • Clinical Lipidology, October 2009, Future Medicine

    Dr Arrigo FG CICERO

  120. Effects of AT1 receptor and beta1 receptor blocking on blood pressure, peripheral hemodynamic and lipid profile in statin‐treated hypertensive hypercholesterolemic patients

    Article • Fundamental and Clinical Pharmacology, September 2009, Wiley

    Dr Arrigo FG CICERO

  121. Serum cholesterol levels on admission and survival in patients with acute myocardial infarction treated with zofenopril: a post hoc analysis of the Survival of Myocardial Infarction Long‐term Evaluation trial

    Article • Fundamental and Clinical Pharmacology, September 2009, Wiley

    Dr Arrigo FG CICERO

  122. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study

    Article • Metabolism, August 2009, Elsevier

    Dr Arrigo FG CICERO

  123. Omega-3 Polyunsaturated Fatty Acids: Their Potential Role in Blood Pressure Prevention and Management

    Article • Current Vascular Pharmacology, July 2009, Bentham Science Publishers

    Dr Arrigo FG CICERO

  124. Fenofibrate, simvastatin and their combination in the management of dyslipidaemia in type 2 diabetic patients

    Article • Current Medical Research and Opinion, June 2009, Informa Healthcare

    Dr Arrigo FG CICERO

  125. Retrospective descriptive analysis of the physiological kinetics of prostate-specific antigen in men older than 75 years

    Article • Asian Journal of Andrology, May 2009, Medknow

    Dr Arrigo FG CICERO

  126. Oral fat load effects on inflammation and endothelial stress markers in healthy subjects

    Article • Heart and Vessels, May 2009, Springer Science + Business Media

    Dr Arrigo FG CICERO

  127. Effects of Telmisartan and Bisoprolol on Blood Pressure, Peripheral Haemodynamic and Lipid Profile in Statin-Treated Hypertensive Hypercholesterolaemic Patients

    Article • High Blood Pressure & Cardiovascular Prevention, May 2009, Springer Science + Business Media

    Dr Arrigo FG CICERO

  128. Irbesartan and Hydrochlorothiazide Association in the Treatment of Hypertension

    Article • Current Vascular Pharmacology, April 2009, Bentham Science Publishers

    Dr Arrigo FG CICERO

  129. Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial

    Article • Current Medical Research and Opinion, January 2009, Informa Healthcare

    Dr Arrigo FG CICERO

  130. Hypertension and hypercholesterolemia: from theory to cardiovascular disease risk prevention. Second edition

    Article • Hot Topics in Cardiology, January 2009, FB Communication

    Dr Arrigo FG CICERO

  131. Pioglitazone Metabolic Effect in Metformin-Intolerant Obese Patients Treated with Sibutramine

    Article • Internal Medicine, January 2009, Japanese Society of Internal Medicine

    Dr Arrigo FG CICERO

  132. Gender-specific haemodynamic and metabolic effects of a sequential training programme on overweight-obese hypertensives

    Article • Blood Pressure, January 2009, Taylor & Francis

    Dr Arrigo FG CICERO

  133. Effects of Insulin Therapy with Continuous Subcutaneous Insulin Infusion (CSII) in Diabetic Patients: Comparison with Multi-daily Insulin Injections Therapy (MDI)

    Article • Endocrine Journal, January 2009, Japan Endocrine Society

    Dr Arrigo FG CICERO

  134. Practical Recommendations for Familial Combined Hyperlipidemia Diagnosis and Management: An Update

    Article • Vascular Disease Prevention, December 2008, Bentham Science Publishers

    Dr Arrigo FG CICERO

  135. Estimation of Familial Combined Hyperlipoproteinemia Prevalence in a Large Rural Population: The Brisighella Heart Study

    Article • Vascular Disease Prevention, December 2008, Bentham Science Publishers

    Dr Arrigo FG CICERO

  136. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone

    Article • Metabolism, November 2008, Elsevier

    Dr Arrigo FG CICERO

  137. Rosiglitazone Therapy Improves Insulin Resistance Parameters in Overweight and Obese Diabetic Patients Intolerant To Metformin

    Article • Archives of Medical Research, May 2008, Elsevier

    Dr Arrigo FG CICERO

  138. Changes in LDL Fatty Acid Composition as a Response to Olive Oil Treatment Are Inversely Related to Lipid Oxidative Damage: The EUROLIVE Study

    Article • Journal of the American College of Nutrition, April 2008, Taylor & Francis

    Dr Arrigo FG CICERO

  139. Non-pharmacological control of plasma cholesterol levels

    Article • Nutrition Metabolism and Cardiovascular Diseases, February 2008, Elsevier

    Dr Arrigo FG CICERO

  140. Hypertension and hypercholesterolemia: from theory to cardiovascular disease risk prevention

    Article • Hot Topics in Cardiology, January 2008, FB Communication

    Dr Arrigo FG CICERO

  141. Global Cardiovascular Disease Risk Management in Italian Patients with Metabolic Syndrome in the Clinical Practice Setting

    Article • High Blood Pressure & Cardiovascular Prevention, January 2008, Springer Science + Business Media

    Dr Arrigo FG CICERO

  142. Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome

    Article • Heart and Vessels, November 2007, Springer Science + Business Media

    Dr Arrigo FG CICERO

  143. Sources of variability of plasma HDL-cholesterol levels

    Article • Future Lipidology, October 2007, Future Medicine

    Dr Arrigo FG CICERO

  144. Interaction between serum cholesterol levels and the renin–angiotensin system on the new onset of arterial hypertension in subjects with high-normal blood pressure

    Article • Journal of Hypertension, October 2007, Wolters Kluwer Health

    Dr Arrigo FG CICERO

  145. Practical Recommendations for Familial Combined Hyperlipidemia Diagnosis and Management: An Update

    Article • Vascular Disease Prevention, August 2007, Bentham Science Publishers

    Dr Arrigo FG CICERO

  146. Estimation of Familial Combined Hyperlipoproteinemia Prevalence in a Large Rural Population: The Brisighella Heart Study

    Article • Vascular Disease Prevention, May 2007, Bentham Science Publishers

    Dr Arrigo FG CICERO

  147. Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: A sequential, randomized, double-blind clinical trial

    Article • Clinical Therapeutics, April 2007, Elsevier

    Dr Arrigo FG CICERO

  148. Activity and potential role of licofelone in the management of osteoarthritis

    Article • Clinical Interventions in Aging, March 2007, Taylor & Francis

    Dr Arrigo FG CICERO

  149. Blood Pressure Modulating Properties of Omega-3 Polyunsaturated Fatty Acids (PUFA)

    Article • High Blood Pressure & Cardiovascular Prevention, January 2007, Springer Science + Business Media

    Dr Arrigo FG CICERO

  150. Blood Pressure Control and Inflammatory Markers in Type 2 Diabetic Patients Treated with Pioglitazone or Rosiglitazone and Metformin

    Article • Hypertension Research, January 2007, Japanese Society of Hypertension

    Dr Arrigo FG CICERO

  151. Effects of Nateglinide and Glibenclamide on Prothrombotic Factors in Naïve Type 2 Diabetic Patients Treated with Metformin: A 1-Year, Double-Blind, Randomized Clinical Trial

    Article • Internal Medicine, January 2007, Japanese Society of Internal Medicine

    Dr Arrigo FG CICERO

  152. Different Effect of Psyllium and Guar Dietary Supplementation on Blood Pressure Control in Hypertensive Overweight Patients: A Six-Month, Randomized Clinical Trial

    Article • Clinical and Experimental Hypertension, January 2007, Taylor & Francis

    Dr Arrigo FG CICERO

  153. Metalloproteinase-2 and -9 in Diabetic and Nondiabetic Subjects during Acute Coronary Syndromes

    Article • Endothelium, January 2007, Taylor & Francis

    Dr Arrigo FG CICERO

  154. Persistence on Treatment and Blood Pressure Control with Different First-Line Antihypertensive Treatments: A Prospective Evaluation

    Article • Clinical and Experimental Hypertension, January 2007, Taylor & Francis

    Dr Arrigo FG CICERO

  155. Fixed combination of zofenopril plus hydrochlorothiazide in the management of hypertension: a review of available data

    Article • Vascular Health and Risk Management, December 2006, Taylor & Francis

    Dr Arrigo FG CICERO

  156. Irbesartan: a review of its use alone and in combination with hydrochlorothiazide

    Article • Therapy, November 2006, Future Medicine

    Dr Arrigo FG CICERO

  157. Physical activity, exercise and cardiovascular health

    Article • Future Lipidology, October 2006, Future Medicine

    Dr Arrigo FG CICERO

  158. Recent evidence of the role of omega-3 polyunsaturated fatty acids on blood pressure control and hypertension-related complications

    Article • Future Lipidology, October 2006, Future Medicine

    Dr Arrigo FG CICERO

  159. Omega-3 polyunsaturated fatty acids: Their potential role in blood pressure prevention and management

    Article • Heart International, September 2006, Wichtig

    Dr Arrigo FG CICERO

  160. Metabolic syndrome prevalence in Italy

    Article • Nutrition Metabolism and Cardiovascular Diseases, September 2006, Elsevier

    Dr Arrigo FG CICERO

  161. Fixed-dose combination rosiglitazone/glimepiride in the treatment of Type 2 diabetes mellitus

    Article • Therapy, September 2006, Future Medicine

    Dr Arrigo FG CICERO

  162. Effects of 1 Year of Treatment with Pioglitazone or Rosiglitazone Added to Glimepiride on Lipoprotein (a) and Homocysteine Concentrations in Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome: A Multicenter, Randomized, Double-Blind, Control...

    Article • Clinical Therapeutics, May 2006, Elsevier

    Dr Arrigo FG CICERO

  163. Effect of Doxazosin on C-Reactive Protein Plasma Levels and on Nitric Oxide in Patients With Hypertension

    Article • Journal of Cardiovascular Pharmacology, April 2006, Wolters Kluwer Health

    Dr Arrigo FG CICERO

  164. Recommendations for the Treatment of Hypertension in Patients with DM: Critical Evaluation Based on Clinical Trials

    Article • Current Clinical Pharmacology, January 2006, Bentham Science Publishers

    Dr Arrigo FG CICERO

  165. Telmisartan and Irbesartan Therapy in Type 2 Diabetic Patients Treated with Rosiglitazone: Effects on Insulin-Resistance, Leptin and Tumor Necrosis Factor-.ALPHA.

    Article • Hypertension Research, January 2006, Japanese Society of Hypertension

    Dr Arrigo FG CICERO

  166. Matrix Metalloproteinase-2, -9, and Tissue Inhibitor of Metalloproteinase-1 in Patients with Hypertension

    Article • Endothelium, January 2006, Taylor & Francis

    Dr Arrigo FG CICERO

  167. Synergistic Effect of Doxazosin and Acarbose in Improving Metabolic Control in Patients with Impaired Glucose Tolerance

    Article • Clinical Drug Investigation, January 2006, Springer Science + Business Media

    Dr Arrigo FG CICERO

  168. Matrix Metalloproteinase-2, -9 and Tissue Inhibitor Metalloproteinase-1 in Patients with Hypertension Before and After Doxazosin Therapy

    Article • High Blood Pressure & Cardiovascular Prevention, January 2006, Springer Science + Business Media

    Dr Arrigo FG CICERO

  169. Antihyperlipidaemic effect of a Monascus purpureus brand dietary supplement on a large sample of subjects at low risk for cardiovascular disease: A pilot study

    Article • Complementary Therapies in Medicine, December 2005, Elsevier

    Dr Arrigo FG CICERO

  170. Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: A 12-month, double-blind, randomized clinical trial

    Article • Clinical Therapeutics, September 2005, Elsevier

    Dr Arrigo FG CICERO

  171. A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome

    Article • Diabetes Research and Clinical Practice, July 2005, Elsevier

    Dr Arrigo FG CICERO

  172. Effects of Doxazosin and Irbesartan on Blood Pressure and Metabolic Control in Patients with Type 2 Diabetes and Hypertension

    Article • Journal of Cardiovascular Pharmacology, June 2005, Wolters Kluwer Health

    Dr Arrigo FG CICERO

  173. Antithrombotic Effects of Rosiglitazone-Metformin versus Glimepiride-Metformin Combination Therapy in Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, May 2005, Wiley

    Dr Arrigo FG CICERO

  174. Adverse reactions related to drugs for headache treatment: clinical impact

    Article • European Journal of Clinical Pharmacology, January 2005, Springer Science + Business Media

    Dr Arrigo FG CICERO

  175. Complementary and Alternative Medicine for Hypertension

    Article • Evidence-Based Integrative Medicine, January 2005, Springer Science + Business Media

    Dr Arrigo FG CICERO

  176. Combined Lipoxygenase/Cyclo-oxygenase Inhibition in the Elderly

    Article • Drugs & Aging, January 2005, Springer Science + Business Media

    Dr Arrigo FG CICERO

  177. Thiazolidinedione Effects on Blood Pressure in Diabetic Patients with Metabolic Syndrome Treated with Glimepiride

    Article • Hypertension Research, January 2005, Japanese Society of Hypertension

    Dr Arrigo FG CICERO

  178. Effect of oral chronic isoflavones supplementation on male rat sexual performances and sexual hormone plasma levels

    Article • Phytotherapy Research, October 2004, Wiley

    Dr Arrigo FG CICERO

  179. Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, do...

    Article • Clinical Therapeutics, August 2004, Elsevier

    Dr Arrigo FG CICERO

  180. Clinical perspectives of anti-inflammatory therapy in the elderly: the lipoxigenase (LOX)/cycloxigenase (COX) inhibition concept

    Article • Archives of Gerontology and Geriatrics, May 2004, Elsevier

    Dr Arrigo FG CICERO

  181. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: A twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial

    Article • Clinical Therapeutics, May 2004, Elsevier

    Dr Arrigo FG CICERO

  182. Effects of a new low dose soy protein/?-sitosterol association on plasma lipid levels and oxidation

    Article • European Journal of Nutrition, January 2004, Springer Science + Business Media

    Dr Arrigo FG CICERO

  183. A randomized, double-blind, controlled, parallel-group comparison of perindopril and candesartan in hypertensive patients with type 2 diabetes mellitus

    Article • Clinical Therapeutics, July 2003, Elsevier

    Dr Arrigo FG CICERO

  184. The effect of l-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus

    Article • Clinical Therapeutics, May 2003, Elsevier

    Dr Arrigo FG CICERO

  185. Clinical considerations preliminary to application of the Italian Society for the Study of Headache's guidelines regarding migraine prophylactic treatment

    Article • The Journal of Headache and Pain, April 2003, Springer Science + Business Media

    Dr Arrigo FG CICERO

  186. It Is Necessary to Prevent a Cerebrovascular ‘Pandemia’

    Article • Cerebrovascular Diseases, January 2003, Karger Publishers

    Dr Arrigo FG CICERO

  187. Cerebrovascular Disease in Italy and Europe: It Is Necessary to Prevent a ‘Pandemia’

    Article • Gerontology, January 2003, Karger Publishers

    Dr Arrigo FG CICERO

  188. Asymptomatic Massive Hypertriglyceridemia in an Octogenarian

    Article • Medical Principles and Practice, January 2003, Karger Publishers

    Dr Arrigo FG CICERO

  189. Effects of a New Soy/β-Sitosterol Supplement on Plasma Lipids in Moderately Hypercholesterolemic Subjects

    Article • Journal of the American Dietetic Association, December 2002, Elsevier

    Dr Arrigo FG CICERO

  190. Letter to Editor: Hypercholesterolemia underdiagnosis and undertreatment in psychiatric patients in Italy

    Article • European Journal of Epidemiology, April 2002, Springer Science + Business Media

    Dr Arrigo FG CICERO

  191. Application of a New Processing Method to Post-LDL-apheresis Data

    Article • Journal of Theoretical Medicine, January 2002, Hindawi Publishing Corporation

    Dr Arrigo FG CICERO

  192. Triptans: the experience of a clinical pharmacologist in clinical practice

    Article • The Journal of Headache and Pain, September 2001, Springer Science + Business Media

    Dr Arrigo FG CICERO